QIAseq Targeted DNA IO Panel (12)

Targeted next-generation sequencing for immuno-oncology research, this QIAGEN panel enriches genomic regions relevant to tumor immunogenicity and immune response. Built around Unique Molecular Index (UMI) technology, the panel enables accurate detection of low-frequency variants by correcting PCR and sequencing errors, supporting reliable determination of tumor mutational burden (TMB), microsatellite instability (MSI) status, and somatic mutations in key immuno-oncology genes. The kit is configured for 12 indexed samples per run, streamlining multiplexed library preparation for translational studies. The workflow is compatible with Illumina sequencing platforms, and input requirements typically start at 40 ng of genomic DNA. Store kit components at -20°C to maintain reagent stability across multiple freeze-thaw cycles. Intended for in vitro research use, this panel integrates with QIAGEN's secondary analysis pipeline for variant calling and immune signature reporting.